Show simple item record

dc.contributor.authorKim, Yeon-Ju
dc.contributor.authorKim, Hyun-Nam
dc.contributor.authorPark, Eui-Kyun
dc.contributor.authorLee, Byung-Heon
dc.contributor.authorRyoo, Hyun-Mo
dc.contributor.authorKim, Shin-Yoon
dc.contributor.authorKim, In-San
dc.contributor.authorStein, Janet L.
dc.contributor.authorLian, Jane B.
dc.contributor.authorStein, Gary S.
dc.contributor.authorVan Wijnen, Andre J.
dc.contributor.authorChoi, Je-Yong
dc.date2022-08-11T08:08:59.000
dc.date.accessioned2022-08-23T16:14:49Z
dc.date.available2022-08-23T16:14:49Z
dc.date.issued2005-11-30
dc.date.submitted2008-10-15
dc.identifier.citationGene. 2006 Jan 17;366(1):145-51. Epub 2005 Nov 28. <a href="http://dx.doi.org/10.1016/j.gene.2005.08.021 ">Link to article on publisher's site</a>
dc.identifier.issn0378-1119 (Print)
dc.identifier.doi10.1016/j.gene.2005.08.021
dc.identifier.pmid16314050
dc.identifier.urihttp://hdl.handle.net/20.500.14038/33952
dc.description.abstractOsterix is a bone-related transcription factor that functions genetically downstream of Runx2, which controls both growth and differentiation in osteoblasts. Here we assessed the biological function of Osterix in mesenchymal cells that are not normally committed to the osteogenic lineage. Stably transfected NIH3T3 fibroblasts that express exogenous Osterix were examined for their ability to convert into osteoblastic cells by analyzing gene expression profiles of bone phenotype related markers, as well as by measuring bone nodule formation and cell proliferation. Forced expression of Osterix stimulates osteopontin gene expression but not the expression or activity of other bone-related markers, including collagen type I, alkaline phosphatase, osteocalcin, or osteonectin. Moreover, cells stably expressing Osterix do not induce bone nodule formation. Strikingly, both polyclonal and monoclonal cells expressing Osterix exhibit enhanced proliferation. Collectively, these results indicate that Osterix is insufficient to establish osteogenic lineage commitment, perhaps due to the ability of Osterix to promote cell growth. We propose that regulatory pathways operating upstream of or in parallel with Osterix are required for osteogenic conversion of uncommitted mesenchymal cells.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16314050&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.gene.2005.08.021
dc.subjectAnimals; Antigens, Differentiation; Cell Differentiation; *Cell Proliferation; Core Binding Factor Alpha 1 Subunit; Gene Expression Regulation; Mesoderm; Mice; NIH 3T3 Cells; Osteoblasts; Osteogenesis; Signal Transduction; Transcription Factors; Transfection
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleThe bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells
dc.typeJournal Article
dc.source.journaltitleGene
dc.source.volume366
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/604
dc.identifier.contextkey651074
html.description.abstract<p>Osterix is a bone-related transcription factor that functions genetically downstream of Runx2, which controls both growth and differentiation in osteoblasts. Here we assessed the biological function of Osterix in mesenchymal cells that are not normally committed to the osteogenic lineage. Stably transfected NIH3T3 fibroblasts that express exogenous Osterix were examined for their ability to convert into osteoblastic cells by analyzing gene expression profiles of bone phenotype related markers, as well as by measuring bone nodule formation and cell proliferation. Forced expression of Osterix stimulates osteopontin gene expression but not the expression or activity of other bone-related markers, including collagen type I, alkaline phosphatase, osteocalcin, or osteonectin. Moreover, cells stably expressing Osterix do not induce bone nodule formation. Strikingly, both polyclonal and monoclonal cells expressing Osterix exhibit enhanced proliferation. Collectively, these results indicate that Osterix is insufficient to establish osteogenic lineage commitment, perhaps due to the ability of Osterix to promote cell growth. We propose that regulatory pathways operating upstream of or in parallel with Osterix are required for osteogenic conversion of uncommitted mesenchymal cells.</p>
dc.identifier.submissionpathgsbs_sp/604
dc.contributor.departmentDepartment of Cell Biology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages145-51


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record